Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes.
Saved in:
| Title: | Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes. |
|---|---|
| Authors: | Vermeire, Séverine1 (AUTHOR) Severine.Vermeire@uzleuven.be, Hanzel, Jurij2 (AUTHOR), Löwenberg, Mark3 (AUTHOR), Ferrante, Marc1 (AUTHOR), Bossuyt, Peter4 (AUTHOR), Hoentjen, Frank5,6 (AUTHOR), Franchimont, Denis7 (AUTHOR), Palatka, Károly8 (AUTHOR), Peeters, Harald9 (AUTHOR), Mookhoek, Aart10 (AUTHOR), Hertogh, Gert de11 (AUTHOR), Molnár, Tamás12 (AUTHOR), Moerkercke, Wouter van1,13 (AUTHOR), Lobatón, Triana14,15 (AUTHOR), Clasquin, Esmé3 (AUTHOR), Hulshoff, Melanie S3 (AUTHOR), Baert, Filip16 (AUTHOR), D'Haens, Geert3 (AUTHOR), group, LOVE-UC study (AUTHOR) |
| Source: | Journal of Crohn's & Colitis. Apr2024, Vol. 18 Issue 4, p540-547. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
